Researchers are constantly trying to get ahead of designer drugs and their ever-changing formulas. Mass spectroscopy is a vital component of that.
read more
In a proof-of-concept, a team has designed injectable nanoparticles that released naloxone when triggered by blue light.
read more
A newly developed prediction model may be able to calculate the risk of opioid relapse among individuals in the early stages of medication treatment—as early as three weeks into therapy.
read more
The body tends to clear drug metabolites within one week, and often sooner. Therefore, detecting drug use after the fact presents a challenge.
read more
Researchers in England used real-world data of fatal opioid overdoses to show that naloxone-delivering drones reach patients in 7 minutes or less in 78% of cases—compared with 14% reached by ambulances in that timeframe.
read more
These investments will help Ohio law enforcement secure critical tools and equipment to keep communities safe, as well as enhance access to prevention, treatment, and recovery services for individuals with substance abuse disorders.
read more
Over the past decade, the illicit drug trade primarily developed and used fentanyl analogs.
read more
New research suggests that in Oregon and Washington, two states that implemented drug decriminalization policies in early 2021, there is no evidence of an association between decriminalization and fatal drug overdose rates.
read more
At issue are post-overdose outreach programs, which are designed to reach out to people who have recently survived an overdose.
read more
New research out of UCLA shows the proportion of overdose deaths in the U.S. involving both fentanyl and stimulants has increased more than 50-fold since 2010—from 0.6% (235 deaths) in 2010 to 32.3% (34,429 deaths) in 2021.
read more